A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in ...

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...

Andrew Teschendorff, Professor at the Chinese Academy of Sciences, is developing computational systems-biological tools to ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

New research results now published from Lund University's MASAI trial are even better than the initial findings from last ...

"By leveraging the tissue-agnostic capabilities of Virchow V2, Paige PanCancer Detect transforms cancer detection into a broad, scalable AI solution that generalizes the concept of 'cancer' across ...

A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S.

A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...